Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845646 | PMC |
http://dx.doi.org/10.1016/j.hrcr.2022.10.018 | DOI Listing |
Eur Heart J Case Rep
November 2024
Department of Thoracic and Cardiovascular Surgery, Saga University, 5 -1-1 Nabeshima, Saga Shi, Saga Ken 849-8501, Japan.
Int J Cardiol
January 2025
Department of Cardiology, Mayo Clinic, Phoenix, AZ, United States of America.
Background: Anatomical factors may preclude transfemoral (TF) arterial access for transcatheter aortic valve implantation (TAVI). Transcaval (TCav) access has been utilized as an alternative access for these patients. We aimed to investigate the outcomes of TCav access in patients undergoing TAVI.
View Article and Find Full Text PDFKardiol Pol
November 2024
Clinical Department of Interventional Cardiology, St. John Paul II Hospital, Kraków, Poland.
Vasc Endovascular Surg
February 2025
Division of Vascular Surgery, Department of Surgery, University of Maryland, Baltimore, MD, USA.
J Clin Med
August 2024
Department of Cardiac Surgery, Royal Papworth Hospital NHS Foundation Trust, Cambridge CB2 0AY, UK.
Transcatheter aortic valve implantation (TAVI) has revolutionised the management of severe aortic stenosis, particularly for patients deemed high risk or inoperable for traditional surgical aortic valve replacement. The transfemoral approach is the preferred route whenever feasible, attributed to its minimally invasive nature, reduced procedural morbidity, and shorter recovery times. In total, 80-90% of TAVI procedures are performed via the transfemoral route.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!